XML 42 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury stock
Retained Earnings
Beginning Balance at Mar. 31, 2017 $ 2,436,250 $ 116 $ 2,693,846 $ (3,472) $ (570,921) $ 316,681
Beginning Balance (in shares) at Mar. 31, 2017   115,917,431     23,876,143  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 79,812         79,812
Unrealized net investment gains (losses) (6)     (6)    
Unrealized net gains (losses) on derivative financial instruments 131     131    
Cumulative translation adjustments 4,889     4,889    
Recognition of actuarial net gains (losses) from pension and other post-retirement plan 1,353     1,353    
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,216,535        
Stock-based compensation expense for restricted stock units granted to employees 43,425   43,425      
Issuance of common stock under employee stock purchase plan 17,849   17,849      
Issuance of common stock under employee stock purchase plan (in shares)   610,947        
Repurchase of treasury stock (514,922)   (90,000)   $ (424,922)  
Repurchase of treasury stock (in shares)         13,598,747  
Ending Balance at Mar. 31, 2018 2,068,782 $ 117 2,665,120 2,895 $ (995,843) 396,493
Ending Balance (in shares) at Mar. 31, 2018   117,744,913     37,474,890  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (73,324)         (73,324)
Unrealized net investment gains (losses) 60     60    
Unrealized net gains (losses) on derivative financial instruments (87)     (87)    
Cumulative translation adjustments (3,229)     (3,229)    
Recognition of actuarial net gains (losses) from pension and other post-retirement plan (2,278)     (2,278)    
Issuance of common stock pursuant to vesting of restricted stock units 3 $ 3        
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,438,219        
Stock-based compensation expense for restricted stock units granted to employees 51,945   51,945      
Issuance of common stock under employee stock purchase plan 15,074   15,074      
Issuance of common stock under employee stock purchase plan (in shares)   577,000        
Repurchase of treasury stock (26,437)   96,783   $ (123,220)  
Repurchase of treasury stock (in shares)         4,674,881  
Ending Balance at Mar. 31, 2019 2,065,433 $ 120 2,828,922 (2,639) $ (1,119,063) 358,093
Ending Balance (in shares) at Mar. 31, 2019   119,760,132     42,149,771  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,754)         (2,754)
Unrealized net investment gains (losses) 126     126    
Unrealized net gains (losses) on derivative financial instruments (57)     (57)    
Cumulative translation adjustments (1,644)     (1,644)    
Recognition of actuarial net gains (losses) from pension and other post-retirement plan 1,054     1,054    
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,651,284        
Stock-based compensation expense for restricted stock units granted to employees 48,404   48,404      
Issuance of common stock under employee stock purchase plan 14,227   14,227      
Issuance of common stock under employee stock purchase plan (in shares)   594,661        
Repurchase of treasury stock (186,872)     $ (186,872)  
Repurchase of treasury stock (in shares)         7,635,400  
Ending Balance at Mar. 31, 2020 $ 1,937,919 $ 122 $ 2,891,553 $ (3,160) $ (1,305,935) $ 355,339
Ending Balance (in shares) at Mar. 31, 2020   122,006,077     49,785,171